FGF8 and prostate cancer: As part of its hormone-independent prostate cancer promoting effect, the natural HDAC inhibitor trichostatin A (TSA) increased the transcriptional activity of NF-κB in PC3M prostate cancer cells associated with upregulation of fibrose growth factor FGF8[44].